[96a5a0]: / output / allTrials / identified / NCT00003082_identified.json

Download this file

452 lines (452 with data), 21.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
{
"info": {
"nct_id": "NCT00003082",
"official_title": "A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS: Refractory or recurrent advanced malignancy following known standard effective therapy or advanced malignancy for which no standard effective therapy exists Measurable or evaluable disease\n\nPATIENT CHARACTERISTICS: Age: 18 and over Performance status: SWOG 0-2 Life expectancy: At least 2 months Hematopoietic: Absolute neutrophil count at least 1800/mm3 Hematocrit at least 30 mg/dL Platelet count at least 50,000/mm3 Hepatic: Bilirubin no greater than 1.5 times normal unless due to disease, then less than 3.5 times normal Transaminases less than 3 times upper limit of normal (ULN) (less than 5 times ULN if due to liver metastases) Renal: Creatinine no greater than 2.5 times normal Cardiovascular: No severe cardiac abnormalities Must have adequate venous access No history of sustained ventricular arrhythmia or unexplained syncope Pulmonary: No severe pulmonary abnormalities Other: Not pregnant or nursing Effective contraception required of fertile female patients No serious concurrent medical or psychiatric illness Adequate nutrition No human antimouse antibodies\n\nPRIOR CONCURRENT THERAPY: At least 4 weeks since prior anticancer therapy and recovered If there was disease progression during therapy, at least 2 weeks since prior anticancer therapy and recovered Biologic therapy: Not specified Chemotherapy: No concurrent chemotherapy Endocrine therapy: Concurrent topical steroids used in the chronic management of cutaneous T cell lymphoma allowed No other concurrent hormone therapy Radiotherapy: No concurrent palliative radiotherapy Surgery: Not specified"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "DISEASE CHARACTERISTICS: Refractory or recurrent advanced malignancy following known standard effective therapy or advanced malignancy for which no standard effective therapy exists Measurable or evaluable disease",
"criterions": [
{
"exact_snippets": "Refractory or recurrent advanced malignancy",
"criterion": "advanced malignancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"refractory",
"recurrent"
]
}
]
},
{
"exact_snippets": "following known standard effective therapy",
"criterion": "standard effective therapy",
"requirements": [
{
"requirement_type": "status",
"expected_value": "completed"
}
]
},
{
"exact_snippets": "advanced malignancy for which no standard effective therapy exists",
"criterion": "advanced malignancy",
"requirements": [
{
"requirement_type": "standard therapy availability",
"expected_value": false
}
]
},
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"measurable",
"evaluable"
]
}
]
}
]
},
{
"line": "PATIENT CHARACTERISTICS: Age: 18 and over Performance status: SWOG 0-2 Life expectancy: At least 2 months Hematopoietic: Absolute neutrophil count at least 1800/mm3 Hematocrit at least 30 mg/dL Platelet count at least 50,000/mm3 Hepatic: Bilirubin no greater than 1.5 times normal unless due to disease, then less than 3.5 times normal Transaminases less than 3 times upper limit of normal (ULN) (less than 5 times ULN if due to liver metastases) Renal: Creatinine no greater than 2.5 times normal Cardiovascular: No severe cardiac abnormalities Must have adequate venous access No history of sustained ventricular arrhythmia or unexplained syncope Pulmonary: No severe pulmonary abnormalities Other: Not pregnant or nursing Effective contraception required of fertile female patients No serious concurrent medical or psychiatric illness Adequate nutrition No human antimouse antibodies",
"criterions": [
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "Performance status: SWOG 0-2",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "scale",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "SWOG"
}
}
]
},
{
"exact_snippets": "Life expectancy: At least 2 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "months"
}
}
]
},
{
"exact_snippets": "Absolute neutrophil count at least 1800/mm3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 1800,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Hematocrit at least 30 mg/dL",
"criterion": "hematocrit",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "Platelet count at least 50,000/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 50000,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Bilirubin no greater than 1.5 times normal unless due to disease, then less than 3.5 times normal",
"criterion": "bilirubin",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "times normal"
}
},
{
"requirement_type": "conditional maximum",
"expected_value": {
"operator": "<",
"value": 3.5,
"unit": "times normal"
}
}
]
},
{
"exact_snippets": "Transaminases less than 3 times upper limit of normal (ULN) (less than 5 times ULN if due to liver metastases)",
"criterion": "transaminases",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "times ULN"
}
},
{
"requirement_type": "conditional maximum",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "times ULN"
}
}
]
},
{
"exact_snippets": "Creatinine no greater than 2.5 times normal",
"criterion": "creatinine",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "times normal"
}
}
]
},
{
"exact_snippets": "No severe cardiac abnormalities",
"criterion": "cardiac abnormalities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": false
}
]
},
{
"exact_snippets": "Must have adequate venous access",
"criterion": "venous access",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "No history of sustained ventricular arrhythmia or unexplained syncope",
"criterion": "history of sustained ventricular arrhythmia or unexplained syncope",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No severe pulmonary abnormalities",
"criterion": "pulmonary abnormalities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": false
}
]
},
{
"exact_snippets": "Not pregnant or nursing",
"criterion": "pregnancy or nursing",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "Effective contraception required of fertile female patients",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "requirement",
"expected_value": true
}
]
},
{
"exact_snippets": "No serious concurrent medical or psychiatric illness",
"criterion": "serious concurrent medical or psychiatric illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Adequate nutrition",
"criterion": "nutrition",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "No human antimouse antibodies",
"criterion": "human antimouse antibodies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY: At least 4 weeks since prior anticancer therapy and recovered If there was disease progression during therapy, at least 2 weeks since prior anticancer therapy and recovered Biologic therapy: Not specified Chemotherapy: No concurrent chemotherapy Endocrine therapy: Concurrent topical steroids used in the chronic management of cutaneous T cell lymphoma allowed No other concurrent hormone therapy Radiotherapy: No concurrent palliative radiotherapy Surgery: Not specified",
"criterions": [
{
"exact_snippets": "At least 4 weeks since prior anticancer therapy",
"criterion": "time since prior anticancer therapy",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior anticancer therapy",
"requirements": [
{
"requirement_type": "recovery status",
"expected_value": true
}
]
},
{
"exact_snippets": "disease progression during therapy, at least 2 weeks since prior anticancer therapy",
"criterion": "time since prior anticancer therapy after disease progression",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior anticancer therapy after disease progression",
"requirements": [
{
"requirement_type": "recovery status",
"expected_value": true
}
]
},
{
"exact_snippets": "Biologic therapy: Not specified",
"criterion": "biologic therapy",
"requirements": [
{
"requirement_type": "specification",
"expected_value": "Not specified"
}
]
},
{
"exact_snippets": "No concurrent chemotherapy",
"criterion": "concurrent chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Concurrent topical steroids used in the chronic management of cutaneous T cell lymphoma allowed",
"criterion": "concurrent topical steroids for cutaneous T cell lymphoma",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
},
{
"exact_snippets": "No other concurrent hormone therapy",
"criterion": "concurrent hormone therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No concurrent palliative radiotherapy",
"criterion": "concurrent palliative radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Surgery: Not specified",
"criterion": "surgery",
"requirements": [
{
"requirement_type": "specification",
"expected_value": "Not specified"
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}